drugset / Trial / NCT02168543

1% Alendronate Gel in Treatment of Chronic Periodontitis Among Smokers

NCT02168543

RandomizedParallel-groupTriple-blindTreatment

Summary

* Locally delivered Alendronate (ALN) have potent inhibitory effect on bone and increases new bone formation in chronic periodontitis patients * Till date no study has reported the effect of local delivery of ALN in chronic periodontitis patients among smokers. Hence the aim of this study is to investigate the clinical and radiographic effects of locally delivered ALN as an adjunct to the non surgical treatment in smoker chronic periodontitis patients.

Timeline

Start
2009-03
Primary completion
2011-01
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Alendronic Acid Small molecule 1 % Other

Indications